Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus

NCT02229227 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

814

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Albiglutide
DRUG: Insulin Glargine and Insulin Lispro

Sponsor

GlaxoSmithKline

Collaborators

[object Object]